--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 0.000--
Microsoft
MSFT
Salesforce
CRM
MARA Holdings
MARA
Apple
AAPL
KB Home
KBH
US Stock MarketDetailed Quotes
OLMA Olema Pharmaceuticals
- 7.000
- -1.410-16.77%
Trading Dec 12 12:06 ET
516.65MMarket Cap-3.07P/E (TTM)
8.480High6.500Low1.98MVolume8.390Open8.410Pre Close13.97MTurnover4.06%Turnover RatioLossP/E (Static)73.81MShares16.77552wk High2.60P/B340.98MFloat Cap6.50052wk Low--Dividend TTM48.71MShs Float60.270Historical High--Div YieldTTM23.54%Amplitude2.000Historical Low7.066Avg Price1Lot Size
Olema Pharmaceuticals Key Stats
Olema Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Olema Pharmaceuticals Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data